For: | Chen G, Qiu H, Ke SD, Hu SM, Yu SY, Zou SQ. Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling. World J Gastroenterol 2013; 19(16): 2481-2491 [PMID: 23674849 DOI: 10.3748/wjg.v19.i16.2481] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i16/2481.htm |
Number | Citing Articles |
1 |
Wu Liu, Eskandar Qaed, Yuelin Zhu, Wenzhang Tian, Yizhen Wang, Le Kang, Xiaodong Ma, Zeyao Tang. Research Progress and New Perspectives of Anticancer Effects of Emodin. The American Journal of Chinese Medicine 2023; 51(07): 1751 doi: 10.1142/S0192415X23500787
|
2 |
Xinyan Xue, Yunyun Quan, Lihong Gong, Xiaohong Gong, Yunxia Li. A review of the processed Polygonum multiflorum (Thunb.) for hepatoprotection: Clinical use, pharmacology and toxicology. Journal of Ethnopharmacology 2020; 261: 113121 doi: 10.1016/j.jep.2020.113121
|
3 |
Mohan Shankar G., Mundanattu Swetha, C K Keerthana, Tennyson P Rayginia, Ruby John Anto. Cancer Chemoprevention: A Strategic Approach Using Phytochemicals. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.809308
|
4 |
Yue Hu, Lin Yang, Yu Lai. Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms. Biomedicine & Pharmacotherapy 2023; 162: 114585 doi: 10.1016/j.biopha.2023.114585
|
5 |
Subash Chandra Gupta, Vipin Rai. Role of Nutraceuticals in Chemoresistance to Cancer. 2018; : 241 doi: 10.1016/B978-0-12-812373-7.00012-7
|